Hikal Limited has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a net loss of ₹75 million for the quarter. Revenue from operations stood at ₹4,028 million. The report also details changes in expenses, including a significant increase in cost of materials consumed and a decrease in exceptional items impacting the profit before tax.
Hikal Announces Q1 FY27 Financial Results
Hikal Limited has released its unaudited financial results for the first quarter of the fiscal year 2027, ending on June 30, 2026. The company posted a net loss of ₹75 million for the quarter. This compares to a profit of ₹146 million in the preceding quarter (ended March 31, 2026) and a loss of ₹227 million in the corresponding quarter of the previous year (ended June 30, 2025).
Key Financial Highlights
The total revenue from operations for the quarter was ₹4,028 million, a decrease from ₹5,194 million in the previous quarter and slightly higher than ₹3,804 million in the year-ago period. Expenses saw notable changes, with the cost of materials consumed at ₹1,940 million and employee benefits expense at ₹744 million for the consolidated results.
Profitability and Comprehensive Income
The company reported a loss before tax after exceptional items of ₹99 million for the quarter. For the quarter ended June 30, 2026, the total comprehensive income attributable to equity holders of the parent was a loss of ₹72 million. Earnings per share (EPS) for the quarter were basic and diluted at (₹0.60).
Segment Performance Overview
In terms of segment-wise performance, the Pharmaceuticals segment reported revenue from operations of ₹2,333 million and a profit before tax of ₹75 million. The Crop Protection segment generated revenue from operations of ₹1,695 million and recorded a loss before tax of ₹60 million. Segment assets for Pharmaceuticals stood at ₹14,402 million, while for Crop Protection, it was ₹8,330 million.
Corporate Actions and Notes
The trading window, which was closed from July 01, 2026, is set to reopen on August 09, 2026. However, a special closure for Directors, KMPs, and specified Senior Management Personnel continues until further notice. The Board of Directors meeting commenced at 11:00 a.m. and concluded at 02:34 p.m. on August 06, 2026.
Source: BSE
